Ohemeng Kwasi
4 Papers
69 Citations
Ohemeng Kwasi is an academic researcher. The author has contributed to research in topics: Prodrug & Covalent bond. The author has an hindex of 1, co-authored 4 publications.
Chat about Author
Papers
Patent
Substituted tetracycline compounds
Paul Abato,Haregewein Assefa,Joel Berniac,Todd Bowser,Beena Bhatia,Jackson Chen,Mark Grier,Laura Honeyman,Mohammed Y. Ismail,Mark L. Nelson,Ohemeng Kwasi,Jingwen Pan +11 more
- 25 Oct 2005
TL;DR: In this article, substituted tetracycline compounds can be used to treat numerous tetracecline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for TTC compounds such as blocking TTC efflux and modulation of gene expression.
69
Patent
Prodrug of 9-aminomethyl tetracycline compound
Ohemeng Kwasi,クワスル オヘメング,Victor Amoo,ビクター アムー,Oak K. Kim,オーク キム,Todd Bowser,トッド ボウザー,Haregewein Assefa,ハレゲウェイン アセッファ,Beena Bhatia,ビーナ バーティア,Joel Berniac,ジョエル バーニアック,Jackson Chen,ジャクソン チェン,Mark Grier,マーク グリアー,Laura Honeyman,ローラ ハニーマン,Jingwen Pan,ジャンウェン パン,Rachid Mechiche,ラシッド メシシュ +23 more
- 12 Oct 2010
TL;DR: In this article, the problem of providing a prodrug of 9-aminomethyl substituted tetracycline compound and a method for using the compound, and a pharmaceutical composition comprising the compound was addressed.
Patent
Composés de tétracycline substitués
Paul Abato,Haregewein Assefa,Joel Berniac,Todd Bowser,Beena Bhatia,Jackson Chen,Mark Grier,Laura Honeyman,Mohammed Y. Ismail,Mark L. Nelson,Ohemeng Kwasi,Jingwen Pan +11 more
- 25 Oct 2005
TL;DR: The authors concerne, au moins en partie, des composes de tetracycline substitues, pouvant etre utilises for le traitement de nombreux etats reagissant a un compose de ce type, du type infections bacteriennes et neoplasmes, and for d'autres applications connues relativement a de tels composes, comme le blocage de l'efflux de tetricylcecline and la modulation of l'expression genique.